Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zon

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Journal of the National Cancer Institute|April 3, 1996
Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in miceC Leonetti, I D'Agnano, F Lozupone, et al.
The Journal of Clinical Investigation|November 1, 1994
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KSB Ensoli, P Markham, V Kao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotideT Skorski, M Nieborowska-Skorska, N C Nicolaides, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
Biologic and therapeutic significance of MYB expression in human melanomaN Hijiya, J Zhang, M Z Ratajczak, et al.
Journal of Virology|November 1, 1993
Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive elementG Li, J Lisziewicz, D Sun, et al.
Antisense Research and Development|January 1, 1994
HIV-1 rev antisense phosphorothioate oligonucleotide binding to human mononuclear cells is cell type specific and inducibleS J Pirruccello, G A Perry, P J Bock, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1996
Amplification of antibody production by phosphorothioate oligodeoxynucleotidesR F Branda, A L Moore, A R Lafayette, et al.
British Journal of Cancer|August 1, 1996
Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivoD Del Bufalo, C Cucco, C Leonetti, et al.
Antisense & Nucleic Acid Drug Development|November 11, 1999
Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotideS D Putney, J Brown, C Cucco, et al.
Nucleic Acids Research|May 25, 1990
Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agentsR P Iyer, B Uznanski, J Boal, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|April 3, 1996
Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in miceC Leonetti, I D'Agnano, F Lozupone, et al.
The Journal of Clinical Investigation|November 1, 1994
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KSB Ensoli, P Markham, V Kao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotideT Skorski, M Nieborowska-Skorska, N C Nicolaides, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
Biologic and therapeutic significance of MYB expression in human melanomaN Hijiya, J Zhang, M Z Ratajczak, et al.
Journal of Virology|November 1, 1993
Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive elementG Li, J Lisziewicz, D Sun, et al.
Antisense Research and Development|January 1, 1994
HIV-1 rev antisense phosphorothioate oligonucleotide binding to human mononuclear cells is cell type specific and inducibleS J Pirruccello, G A Perry, P J Bock, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1996
Amplification of antibody production by phosphorothioate oligodeoxynucleotidesR F Branda, A L Moore, A R Lafayette, et al.
British Journal of Cancer|August 1, 1996
Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivoD Del Bufalo, C Cucco, C Leonetti, et al.
Antisense & Nucleic Acid Drug Development|November 11, 1999
Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotideS D Putney, J Brown, C Cucco, et al.
Nucleic Acids Research|May 25, 1990
Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agentsR P Iyer, B Uznanski, J Boal, et al.
Pageof 15